TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).

Martin J Edelman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.